Presentation of phase Ma results for Cytos Biotechnology's hypertension vaccine at the American Heart Association Scientific Sessions 2007

摘要

Prof. Juerg Nussberger, MD, University Hospital of the Canton of Vaud (CHUV), in Lausanne, Switzerland, presents detailed results of a placebo-controlled, double-blind phase Ⅱa clinical trial with CYT006-AngQb in 72 patients with mild to moderate hypertension. In addition, the American Heart Association publishes at the time of presentation an independent News Release about the vaccine CYT006-AngQb.